ROCHESTER, N.Y.--(BUSINESS WIRE)--Biophan Technologies, Inc. (OTCBB: BIPH - News; FWB: BTN), a developer of next-generation medical technology, announced today full congressional approval of an allocation of $1 million in U.S. government funding to help accelerate the commercialization of the MYO-VAD™ cardiac recovery system. A previously announced additional allocation of $400,000 is still pending.
